v3.26.1
Schedule of Deferred Tax Assets (Details) - USD ($)
Dec. 31, 2025
Dec. 31, 2024
Income Tax Disclosure [Abstract]    
U.S Federal and State net operating loss $ 5,473,294 $ 3,083,545
Stock-based compensation 1,423,288 1,272,925
Accrued salaries 348,012 382,288
Orphan drug credit 1,682,207 1,060,118
Derivative liability
Other 119,699 260,481
Total net deferred tax assets 9,046,500 6,059,357
Valuation allowance (9,046,500) (6,059,357)
Total Deferred Tax Asset